AMA Statements
The AMA continues to urge informed prescribing to reduce opioid-related harm and appreciates the CDC recognizes that patients require individualized care.
Press Releases
The AMA and AMS commended Governor Asa Hutchinson and the General Assembly for removing administrative barriers to treatment for opioid use disorder (OUD).
Opioids
The signs of an overdose, how to administer naloxone, and the toll of stigma covered by experts in a presentation at AMA’s Chicago headquarters.
AMA welcomes FDA including tapering guidance on prescription opioid labels, changes mirror points that AMA has emphasized in efforts to end the opioid epidemic.
Patient Advocacy
In actions that will save lives, New Jersey and Washington, D.C., removed prior authorization for Medicaid patients who need medication-assisted treatment.
Despite potentially harmful consequences of delayed care, health plans not making progress reforming prior authorization process they impose on patient care.
HHS official says two keys to ending the opioid epidemic are finding better ways to treat pain and moving from a crisis framework to a sustainable system.
The AMA presented FDA Commissioner Scott Gottlieb, MD, with the Dr. Nathan Davis Award for Outstanding Government Service.
The AMA presented MA Gov. Charlie Baker with the Dr. Nathan Davis Award for Outstanding Government Service for his decisive action to fight the opioid epidemic.
The AMA presented Village of Mundelein, IL Chief of Police, Eric Guenther with the Dr. Nathan Davis Award for Outstanding Government Service.
